PTC Therapeutics' Application for SMA Drug Accepted by EU

However, competition is stiff in the SMA market from the likes of Biogen's BIIB Spinraza and Novartis' NVS gene therapy, Zolgensma.
https://www.google.com/url?rct=j&sa=t&url=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Fptc-therapeutics-application-sma-drug-210709736.html&ct=ga&cd=CAIyGjkzMDRhMmFkOTExNzExMzY6Y29tOmVuOlVT&usg=AFQjCNGR99zlSzEgLjcrimsX-w2KY0d1oQ&utm_source=dlvr.it&utm_medium=blogger